CL

Clorox CoNYSE CLX Stock Report

Last reporting period 30 Sep, 2024

Updated 13 Nov, 2024

Last price

Market cap $B

20.386

Large

Exchange

XNYS - New York Stock Exchange, Inc

CLX Stock Analysis

CL

Neutral

Based on Eyestock quantitative analysis, CLX`s fundamental data and valuation indicate an investment grade of Neutral at the current time.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

67/100

Moderate score

Upside

To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.

-31.5 %

Overvalued

Market cap $B

20.386

Dividend yield

3.79 %

Shares outstanding

123.53 B

The Clorox Co. engages in the manufacture and marketing of consumer and professional products. The company is headquartered in Oakland, California and currently employs 9,000 full-time employees. The firm operates through four segments: Health and Wellness, Household, Lifestyle and International. The Health and Wellness segments consist of cleaning products, professional products and vitamins, minerals and supplements mainly marketed and sold in the United States. The Household segment consists of bags and wraps, grilling products and cat litter marketed and sold in the United States. The Lifestyle segment consists of food, natural personal care products and water-filtration products marketed and sold in the United States. The International segment consists of products sold outside the United States. The firm's products are sold primarily through mass retailers; grocery outlets; warehouse clubs; dollar stores; home hardware centers; drug, pet and military stores; third-party and owned e-commerce channels, and distributors.

View Section: Eyestock Rating